March 26, 2008
Yale receives grant for statewide clinical trial network
The Connecticut Department of Public Health and the Connecticut Cancer Partnership have awarded Yale Cancer Center a $745,288 grant to launch a statewide clinical trials network to promote cancer research.
The grant is for the development of a clinical trials network and to create the necessary supportive infrastructure to sustain the network on behalf of the state's clinical researchers.
The statewide network will seek to remove existing barriers to clinical trials, promote public education and trial participation, and allow greater access to innovative cancer therapies. A major component of the proposal is to provide pilot funding for supporting investigator-initiated research and capacity building to do cancer clinical trials throughout the state. Approximately 44 percent of the clinical trial network award is committed to the pilot grants program.
The grant is for the development of a clinical trials network and to create the necessary supportive infrastructure to sustain the network on behalf of the state's clinical researchers.
The statewide network will seek to remove existing barriers to clinical trials, promote public education and trial participation, and allow greater access to innovative cancer therapies. A major component of the proposal is to provide pilot funding for supporting investigator-initiated research and capacity building to do cancer clinical trials throughout the state. Approximately 44 percent of the clinical trial network award is committed to the pilot grants program.
"Yale Cancer Center is extremely grateful to have the support of the state and the Connecticut Cancer partnership to begin this important clinical trial initiative in Connecticut," Dr. Edward Chu, deputy director and chief of medical oncology at YCC, said in a statement. "Cancer care in our state will be considerably strengthened by the partnerships created by the new network, and cancer patients throughout the state will have improved access to the cutting edge therapies offered by clinical trials."
WBJ Web Partners
Most Recent
Most Recent
0 Comments